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The concentration of PRPP (phosphoribosyl pyrophosphate) measured in tumor cells grown in monolayer 
showed a large variation with the various harvesting methods examined, including trypsinization. This 
variation could be reduced by a l-h incubation of trypsinized cells as a suspension in Dulbecco’s medium. 
After this preincubation these cell suspensions were suitable for the study of modulation of PRPP. 
OnepM methotrexate caused a 2-3-fold increase and 1 mM N-phosphonoacetyl-L-aspartate a slight 
increase, but inosine and deoxyinosine drastically reduced PRPP concentrations. S-Fluorouracil had no 
effect. This study demonstrates that metabolic parameters uch as PRPP concentrations can be studied 
conveniently in suspensions of cells which are commonly cultivated as monolayers. 
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1. INTRODUCTION 
Phosphoribosyl pyrophosphate (PRPP) plays a 
crucial role in cellular metabolism [l]. It is a high- 
energy phosphate, that serves as a substrate for the 
phosphorylation of purine bases and for rate- 
limiting steps in the de novo synthesis of purine, 
pyrimidine and pyridine nucleotides. The enzymes 
involved in these reactions, phosphoribosyltrans- 
ferases, also catalyze the conversion of various an- 
timetabolites such as SFU (5fluorouracil) and 
6-mercaptopurine to their active forms [2]. Other 
antimetabolites uch as methotrexate (MTX) in- 
crease PRPP levels [3,4]. Biochemical studies on 
PRPP modulation by antimetabolites have been 
carried out predominantly in leukemic cells that 
grow in suspension. Unfortunately, in culture, 
solid tumors only grow in monolayers, which are 
available for biochemical studies only after 
detaching them from the plastic surface of culture 
flasks, usually performed by trypsinization. 
Studies with fibroblasts demonstrated that PRPP 
concentration in these cells is influenced by various 
factors like the harvesting technique, the passage 
number and the culture medium [5,6]. Such 
variables make it difficult to study modulation of 
PRPP in monolayer cells. To be able to perform 
such studies we compared several forms of 
harvesting monolayer cells prior to the measure- 
ment of PRPP concentrations. The study of PRPP 
modulation could be carried out most conveniently 
in monolayer cells harvested by trypsinization. The 
cells were preincubated as a suspension for 1 h 
prior to addition of drugs. 
2. EXPERIMENTAL 
All chemicals and drugs were obtained from 
sources described [7-g]. Cell culture was performed 
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in 75cm2 Falcon flasks in Dulbecco’s medium sup- 
plemented with 15% dialyzed, heat-inactivated 
fetal bovine serum. Origins of the murine B16 
melanoma and the human lGR3 melanoma were 
described in [7]. Cells were passaged every 2-3 
days. Cells for metabolic studies were always 
harvested from cultures in logarithmic growth. 
The monolayers were washed with Hank’s balanced 
salt solution (HBBS) without Ca2+ and Mg” and 
trypsinized at room temperature. Cells were 
suspended in an isotonic Tris-saline buffer 
(50 mM Tris-HCl, 100 mM NaCl, pH 7.4) or in 
Dulbecco’s medium supplemented with 7.5% 
dialyzed, heat-inactivated fetal bovine serum. The 
cells were counted with a hemocytometer, cen- 
trifuged at 200 x g and suspended in an ap- 
propriate incubation medium or assay buffer 
(50 mM Tris-HCl containing 1 mM EDTA, pH 
7.4) for PRPP determinations. PRPP was assayed 
either immediately after harvesting or after storage 
of the cell pellet at - 7O’C. PRPP concentrations 
were determined after suspension of the cell pellet 
in the Tris-EDTA buffer. Fresh cells were lyzed by 
sonication (2 cycles of 5 s at 50 W output, Branson 
sonifier). Frozen cells did not require further lysis 
after suspension of the cell pellet in the 
Tris-EDTA buffer. PRPP concentrations in fresh 
and frozen cells were similar. PRPP concentra- 
tions were determined as in [9,10] by the method 
based on the release of 14C02 from [carboxy- 
“C]orotic acid. The amount of 14C02 was propor- 
tional to the amount of PRPP present in the cell 
extract (0.2-5 x lo6 cells). To prevent interference 
of PRPP metabolizing enzymes, cell extracts were 
denatured before the assay by incubating them 
during 45 s in a boiling water bath. Recovery of 
PRPP during this procedure was measured by ad- 
dition of known amounts of PRPP just before 
boiling to some additional flasks containing cell 
extract [9, lo]. Recovery of PRPP was consistently 
higher than 90% with both cell lines. The presence 
of EDTA prevented consumption of PRPP by 
other enzymes during the heating procedure [lo]. 
The compounds tested for their effects on PRPP 
concentration did not interfere with the assay, 
neither by inhibiting the yeast orotate phosphor- 
ibosyltransferase nor by affecting other enzymes 
since these enzymes were denatured before addi- 
tion of the yeast enzyme. Furthermore, the concen- 
tration of drugs in the assay would be too low to 
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cause interference since only cell pellets were used 
for the assay and not the medium. 
3. RESULTS AND DISCUSSION 
The most suitable buffer for isolation of cells 
prior to PRPP determination in erythrocytes and 
lymphoid cells appeared to be Tris-saline [9,10]. 
With monolayer cells a large variation in PRPP 
concentration was found with this buffer, whereas 
the variation was smaller with Dulbecco’s medium 
(fig.1, t = 0). However, Tris-saline contains no 
nutritional compounds that stimulate PRPP syn- 
thesis or consume PRPP. Therefore PRPP con- 
centrations measured in cells isolated in Tris- 
saline reflect the actual concentration of the cells in 
the monolayers. Further evidence was obtained by 
using harvesting techniques that avoid possible ef- 
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Fig. 1. Effect of a l-h incubation in Dulbecco’s medium 
on the PRPP concentration of B16 and IGR3 melanoma 
cells. The buffers in which the cells were washed were 
Tris-saline and Dulbecco’s medium and are indicated as 
Tris and Dulb, respectively. In one part of the cells 
PRPP concentration was measured immediately after 
harvesting by suspension of the cell pellet in Tris-EDTA 
buffer as described in section 2 (0 h). After 
centrifugation, the other part of the cells was suspended 
in fresh culture medium and incubated at 37°C in a 
shaking water bath. PRPP concentration was measured 
in these cells after a 1 h incubation by centrifugation of 
the cells and suspending them in the Tris-EDTA buffer. 
Lines connect the 0 and 1 h values for the same sample. 
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fects of trypsinization. Cells were harvested by in- 
cubating monolayers in 2 mM EDTA in HBSS 
without Ca2+ and Mg2+ at 37°C for 5-10 min. By 
binding bivalent ions EDTA not only promotes 
detachment of the cells from the plastic surface but 
also inhibits enzymic synthesis and degradation of 
PRPP [lo]. The PRPP concentration in B16 
melanoma cells harvested in this way was com- 
parable to that measured in Tris-saline isolated 
cells from duplicate cultures. Rapid freezing with 
liquid nitrogen fixes cells in their metabolic state 
and appeared to be an adequate method to 
measure PRPP levels in hamster ovary cells [l 11. 
Monolayer cells grown in 6-well cluster plates were 
rapidly frozen with liquid nitrogen after removal 
of the medium. Cells were subsequently lyophil- 
ized and PRPP concentration was measured after 
suspension in the Tris-EDTA buffer. Again the 
concentration of PRPP was comparable to that in 
cells isolated in Tris-saline. 
PRPP concentrations differed in cultures started 
at different time points and harvested in Tris- 
saline prior to assay (fig. 1, t = 0). However, PRPP 
concentrations measured in duplicate flasks or 
dishes grown and harvested simultaneously, were 
comparable. 
The variation in PRPP concentration depending 
on growth conditions, was also reported for 
fibroblasts [5,6]. The fluctuations in PRPP con- 
centrations in fibroblasts are partly due to the 
limited life-span of these non-tumor cells. Yet, the 
condition of the medium appears to be the major 
cause of variation with fibroblasts from a low 
passage number [5]. Substrates for phosphoribo- 
syl-transferases uch as hypoxanthine may be ab- 
sent and this may lead to the increased PRPP con- 
centrations. Isolation buffers that contain 
substrates for PRPP utilization or precursors for 
PRPP synthesis such as glucose, influence the 
PRPP concentration [9]. With melanoma tumor 
cells isolation methods that use buffers without 
nutritional compounds, gave comparable results. 
Therefore the fluctuating concentrations measured 
with Tris-saline represent actual concentrations in 
these cells. 
Although PRPP concentrations could be 
measured reliably by these methods, none of these 
methods could be used to study drug effects in 
monolayer cells which was the main aim of this 
study. Variation in PRPP concentration due to 
culture effects was higher than the effects of drugs 
(not shown). To minimize culture effects we in- 
cubated cells as a suspension in fresh culture 
medium in a shaking water bath at 37°C. The 
range of PRPP concentration declined in cells 
isolated in either Tris-saline or Dulbecco’s 
medium with serum and incubated in Dulbecco’s 
medium. The concentration of PRPP measured in 
11 and 7 separate samples of B16 and IGR3 cells, 
respectively, isolated in Dulbecco’s medium and 
incubated for 1 h in Dulbecco’s medium were 200 
+ 20 and 87 + 10 pmol/106 cells (means k SE). 
Since longer incubations (up to 5 h) did not 
significantly affect PRPP concentrations, these 
cell suspensions were used to study modulation of 
PRPP concentrations (table 1). MTX was included 
in these studies since an enhancement of PRPP 
concentrations has been reported for this drug for 
various leukemic cell lines [3,4]. The increase 
found with B16 cells demonstrates that this 
method can be used to study modulation of PRPP 
in monolayer cell lines. PALA (N-phosphonoace- 
tyl-L-aspartate), an inhibitor of aspartate transcar- 
bamylase, slightly increased PRPP concentrations, 
possibly by depletion of erotic acid (not shown). In 
order to affect cell growth 5FU has to be converted 
to nucleotides. This conversion takes place in a 
Table 1 
Modulation of the PRPP concentration in B16 
melanoma cells 
Drug PRPP concentration 
None 253 + 40 
PALA, 0.1 mM 364 Z!I 38 
PALA, 1 mM 346 + 38 
SFU, 25 pM 252 f 52 
5FU, 50/1M 242 f 52 
MTX, 1 yM 607 + 108 
Inosine, 0.4 mM 41+ 8 
Deoyxinosine, 0.4 mM 26+ 4 
Concentrations (in pmol/106 cells) are means f SE of 
3-5 separate experiments. Cells were harvested by 
trypsinization and suspended in Dulbecco’s medium 
supplemented with 7.5% dialyzed serum. Drugs were 
added after a 1 h preincubation in fresh culture medium 
and PRPP concentrations were measured 2 h later by 
centrifugation of the cells and suspension of the cell 
pellet in Tris-EDTA buffer 
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two-step reaction catalyzed by uridine phosphor- 
ylase and uridine kinase or directly in a reaction 
catalyzed by orotate phosphoribosyl-transferase 
[12] with PRPP as a co-substrate; 5FU did not 
significantly influence PRPP levels, indicating that 
under these conditions 5FU phosphorylation does 
not consume PRPP or that PRPP consumption by 
5FU phosphorylation is compensated by an in- 
creased synthesis. The purine nucleosides, inosine 
and deoxyinosine, decreased PRPP concentration. 
Various mechanisms may account for this decrease 
[ 131. Inhibition of PRPP synthetase does not seem 
probable since both nucleosides do not inhibit the 
enzyme [14]. Hypoxanthine, the phosphorolysis 
product of inosine and deoxyinosine, can reduce 
PRPP levels through its conversion to IMP [3], a 
step which consumes PRPP. IMP is also an in- 
hibitor of PRPP synthetase [14,15]. However, in- 
hibition of PRPP synthesis may predominantly be 
due to a decrease in orthophosphate levels caused 
by phosphorolysis of inosine [ 131. The availability 
of orthophosphate which is an allosteric activator 
of PRPP synthetase, is an important control 
mechanism of PRPP synthesis [13,161 and may ac- 
count for a number of biological effects of 
nucleosides. 
In conclusion, we described a method for the 
measurement of PRPP concentration in mono- 
layer tumor cell lines using Tris-saline as an isola- 
tion buffer. Short-term modulation of PRPP con- 
centrations could be carried in cells isolated in 
Dulbecco’s medium and preincubated for 1 h in 
this medium. These cell suspensions might also be 
used for the study of other metabolic parameters, 
when intact cells are required. 
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